Table 2.
Neonates | ||||
---|---|---|---|---|
Corrected gestational age | Standard empiric dosing guidelines (for comparison) | Dosing | Daily dosing (mg/kg/day), median (IQR) | P value |
<29 w | 15 | Empiric dosing | 14 (13–15) | <.05 |
Dose required | 37 (29–41) | |||
29–≤35 w | 30 | Empiric dosing | 29 (27–30) | |
Dose required | 43 (32–49) | <.01 | ||
35–≤44 w | 45 | Empiric dosing | 45 (44–47) | .62 |
Dose required | 47 (45–60) |
Infants and children | ||||
---|---|---|---|---|
Age | Standard empiric dosing guidelines (for comparison) | Dosing | Daily dosing (mg/kg/day), median (IQR) | P value |
29 d–23 mo | 30–80 | Empiric dosing | 59 (45–60) | .60 |
Dose required | 61 (58–66) | |||
2–18 y | 30–80 | Empiric dosing | 45 (41–58) | <.05 |
Dose required | 60 (51–74) |
IQR, interquartile range; w, weeks.